Felder MAR - Search Results

1

Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist.

Pieper AA, Spiegelman DV, Felder MAR, Feils AS, Tsarovsky NW, Zaborek J, Morris ZS, Erbe AK, Rakhmilevich AL, Sondel PM. Pieper AA, et al. Among authors: felder mar. Cancer Immunol Immunother. 2023 Jul;72(7):2459-2471. doi: 10.1007/s00262-023-03433-3. Epub 2023 Apr 5. Cancer Immunol Immunother. 2023. PMID: 37016127 Free PMC article.

2

Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancer.

Connor JP, Felder M, Hank J, Harter J, Gan J, Gillies SD, Sondel P. Connor JP, et al. J Immunother. 2004 May-Jun;27(3):211-9. doi: 10.1097/00002371-200405000-00005. J Immunother. 2004. PMID: 15076138

3

Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice.

Johnson EE, Buhtoiarov IN, Baldeshwiler MJ, Felder MA, Van Rooijen N, Sondel PM, Rakhmilevich AL. Johnson EE, et al. J Immunother. 2011 Jan;34(1):76-84. doi: 10.1097/CJI.0b013e318200b28a. J Immunother. 2011. PMID: 21150715 Free PMC article.

4

Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects.

Rakhmilevich AL, Baldeshwiler MJ, Van De Voort TJ, Felder MA, Yang RK, Kalogriopoulos NA, Koslov DS, Van Rooijen N, Sondel PM. Rakhmilevich AL, et al. Cancer Immunol Immunother. 2012 Oct;61(10):1683-97. doi: 10.1007/s00262-012-1236-2. Epub 2012 Mar 6. Cancer Immunol Immunother. 2012. PMID: 22392192 Free PMC article.

5

Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice.

Van De Voort TJ, Felder MA, Yang RK, Sondel PM, Rakhmilevich AL. Van De Voort TJ, et al. J Immunother. 2013 Jan;36(1):29-40. doi: 10.1097/CJI.0b013e3182780f61. J Immunother. 2013. PMID: 23211623 Free PMC article.

6

Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma model.

Qu X, Felder MA, Perez Horta Z, Sondel PM, Rakhmilevich AL. Qu X, et al. Int Immunopharmacol. 2013 Dec;17(4):1141-7. doi: 10.1016/j.intimp.2013.10.019. Epub 2013 Nov 4. Int Immunopharmacol. 2013. PMID: 24201083 Free PMC article.

7

Synergy of anti-CD40, CpG and MPL in activation of mouse macrophages.

Shi Y, Felder MA, Sondel PM, Rakhmilevich AL. Shi Y, et al. Mol Immunol. 2015 Aug;66(2):208-15. doi: 10.1016/j.molimm.2015.03.008. Epub 2015 Mar 28. Mol Immunol. 2015. PMID: 25829245 Free PMC article.

8

Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.

Rakhmilevich AL, Felder M, Lever L, Slowinski J, Rasmussen K, Hoefges A, Van De Voort TJ, Loibner H, Korman AJ, Gillies SD, Sondel PM. Rakhmilevich AL, et al. J Immunol. 2017 Feb 15;198(4):1575-1584. doi: 10.4049/jimmunol.1601255. Epub 2017 Jan 6. J Immunol. 2017. PMID: 28062694 Free PMC article.

9

MUC16 suppresses human and murine innate immune responses.

Felder M, Kapur A, Rakhmilevich AL, Qu X, Sondel PM, Gillies SD, Connor J, Patankar MS. Felder M, et al. Gynecol Oncol. 2019 Mar;152(3):618-628. doi: 10.1016/j.ygyno.2018.12.023. Epub 2019 Jan 6. Gynecol Oncol. 2019. PMID: 30626487 Free PMC article.

10

Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model.

Ayuso JM, Truttschel R, Gong MM, Humayun M, Virumbrales-Munoz M, Vitek R, Felder M, Gillies SD, Sondel P, Wisinski KB, Patankar M, Beebe DJ, Skala MC. Ayuso JM, et al. Oncoimmunology. 2018 Dec 12;8(3):1553477. doi: 10.1080/2162402X.2018.1553477. eCollection 2019. Oncoimmunology. 2018. PMID: 30723584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page